STABLE PHARMACEUTICAL COMPOSITION WITH FIXED DOSE, CONTAINING MOMETASONE AND OLOPATADINE Russian patent published in 2019 - IPC A61K31/573 A61K31/55 A61K47/36 A61K47/38 A61K47/04 A61K9/10 A61P11/02 A61P37/08 

Abstract RU 2687551 C2

FIELD: medicine; pharmaceuticals.

SUBSTANCE: present invention relates to a stable, fixed-dose aqueous pharmaceutical suspension composition for nasal administration in humans. Composition contains mometasone furoate in the form of particles, olopatadine hydrochloride in dissolved form, a hydrocolloid selected from sodium carboxymethylcellulose and xanthan gum, water and auxiliary ingredients. Invention also relates to a method of treating rhinitis in humans by administering as a nasal spray or nasal drops. Kit for treating rhinitis and a method for delivering a pharmaceutical aqueous suspension composition using a nebulizer to a person’s nasal passages is also described, with a spray pattern such that the largest axis is 15–75 mm, the smallest axis is 10–65 mm, and ellipticity is 1–2.

EFFECT: suspension composition according to the invention is stable and is characterized by the absence of phase separation for at least 24 hours of storage at 25 ± 2 °C and relative humidity of 60 ± 5 %.

46 cl, 4 ex

Similar patents RU2687551C2

Title Year Author Number
TREATMENT OF ALLERGIC RHINITIS IN PEDIATRIC CATEGORY USING A COMBINATION OF MOMETASONE AND OLOPATADINE 2019
  • Kajratkar-Dzhoshi, Neelima
  • Kulkarni, Abkhaj
  • Vale, Dinesh Pradip
  • Bkhosale, Vikram M.
  • Agarval, Piyush
  • Keokhejn, Patrik
  • Tantri, Sudish K.
  • O, Ched
RU2798030C2
TREATMENT OF ALLERGIC RHINITIS USING A COMBINATION OF MOMETASONE AND OLOPATADIN 2014
  • Khajratkar Dzhoshi, Neelima
  • Kulkarni, Abkhaj
  • Val, Dinesh Pradip
  • Bkhosli, Vikram Mansingkh
  • Agarval, Piyush
  • Keokhejn, Patrik
  • Tantri, Sudish, K.
  • O, Ched
RU2799761C2
TREATMENT OF ALLERGIC RHINITIS USING COMBINATION OF MOMETASONE AND OLOPATADINE 2014
  • Khajratkar Dzhoshi Neelima
  • Kulkarni Abkhaj
  • Val Dinesh Pradip
  • Bkhosli Vikram Mansingkh
  • Agarval Piyush
  • Keokhejn Patrik
  • Tantri Sudish K.
  • O Ched
RU2686670C2
PHARMACEUTICAL COMPOSITION 2005
  • Khak Abu
  • Vejngarten Allen Dzh.
  • Simmons Robert D.
RU2394573C2
PHARMACEUTICAL COMPOSITION, CONTAINING MOMETASONE FUROATE AND AZELASTINE HYDROCHLORIDE, FOR NASAL INTRODUCTION 2011
  • Lee Sang-Yong
  • Lee Geun-Hyeog
  • Choi Byong-Sun
  • Ryu Jong-Hyeon
  • Park Jin-Ha
  • O Mi-Jin
RU2563115C2
COMBINATION OF LEVOCABASTINE AND FLUTICASONE FUROATE FOR THE TREATMENT OF INFLAMMATORY AND/OR ALLERGIC CONDITIONS 2013
  • Ignar Diane Michele
  • Levin Daren Scott
RU2652352C2
AXELASTIN AND STEROIDS COMBINATION 2003
  • Lulla Amar
  • Malkhotra Dzhina
RU2361593C2
DRY PHARMACEUTICAL COMPOSITIONS CONTAINING NANOPARTICLES OF ACTIVE AGENT BOUND TO CARRIER PARTICLES 2014
  • Gvozdz Garri T.
  • Lichti Mejnard Emanuel
RU2715714C2
COMPOSITIONS CONTAINING ANTIBIOTIC AND CORTICOSTEROID 2009
  • Talli Rodzher
  • Frikhof Kejt
  • Bramfild Dzhej
RU2496501C2
NASAL PHARMACEUTICAL COMPOSITIONS AND METHODS OF APPLICATION THEREOF 2004
  • Chaudri Imitjaz
RU2380090C2

RU 2 687 551 C2

Authors

Dkhuppad Ulkhas

Katkurvar Ashok

Gupta Yashvant

Ankam Radzhesh

Dkhatrak Chandrakant

Dates

2019-05-15Published

2014-09-04Filed